Cumulus Neuroscience

Cumulus Neuroscience

Private
BelfastHealthcare & Life Scienceshttps://cumulusneuro.com/

Last Round

Grant

Jul 11, 2024

Total Funding Raised

$18.74M

Company Overview

Cumulus Neuroscience is a healthcare technology company that provides an AI-powered digital biomarker platform with a wearable EEG headset and tablet-based assessments to accelerate clinical trials for central nervous system therapies.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Medical AI, Medical Devices, Health IoT, Healthcare Analytics

Business Model

B2B

Customer Profile

Hardware + Subscription, Services & Consulting, Data as a Service, Government Contracts

AI Layer

Application

Keywords

digital biomarkersCNS clinical trialswearable EEGdecentralized clinical trialsDCT platformneurotechremote patient monitoringRPMdry-sensor EEGclinical trial platformreal-world dataCNSCentral Nervous SystemAI data analyticscognitive assessmentsclinical trial endpointsFDA cleared devicedigital phenotyping

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cumulus Neuroscience Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Cumulus Neuroscience Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
GrantJul 11, 2024
Early FundingJul 8, 2024
Early FundingMay 4, 2021

Key People

Founding team and executive leadership

Siggi Saevarsson

COO

Executive Team

Cumulus Neuroscience Investors

Notable investors and investment history

InvestorRounds
ACF InvestorsEarly Funding
Future Fund (UK Government)Early Funding
Innovate UKGrant
Investment Fund for Northern IrelandEarly Funding
Whiterock's Growth Capital FundEarly Funding
Clarendon Fund ManagersEarly Funding
LifeArcEarly Funding, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 9, 2025

    Monthly visitors increased 43% MoM.

  • May 3, 2025

    Monthly visitors increased 250% MoM.

Cumulus Neuroscience Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Cumulus Neuroscience Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cumulus Neuroscience's valuation, stock price, and market status.

Firmographic Details

HeadquartersBelfast
Employee Range35
Year Founded2015
Last FundingJul 11, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.